secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2026-06-15T21:24:55+00:00
Accession:  0001077183-26-000029
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics commences $275M convertible note offering due 2032
--------------------------------------------------------------

- Offering $275M aggregate principal amount of convertible senior notes due 2032, with option for additional $41.25M.
- Notes offered to qualified institutional buyers under Rule 144A; interest rate and conversion rate set at pricing.
- Proceeds used to repurchase a portion of existing 0.25% convertible notes due 2028 and up to $25M of common stock.
- Company to enter capped call transactions to reduce potential dilution upon conversion.
- The offering is contingent on market conditions and not registered under the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718326000029/0001077183-26-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718326000029/neo-20260615.htm
  HTML page:      https://secwatch.observer/filing/0001077183-26-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer